Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Current Deferred Revenue (2016 - 2025)

Marchex (MCHX) has disclosed Current Deferred Revenue for 16 consecutive years, with $598000.0 as the latest value for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 45.29% year-over-year to $598000.0; the TTM value through Dec 2025 reached $598000.0, down 45.29%, while the annual FY2025 figure was $598000.0, 45.29% down from the prior year.
  • Current Deferred Revenue was $598000.0 for Q4 2025 at Marchex, up from $430000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $2.0 million in Q4 2021, with the low at $430000.0 in Q3 2025.
  • Historically, Current Deferred Revenue has averaged $1.3 million across 5 years, with a median of $1.3 million in 2021.
  • The largest annual shift saw Current Deferred Revenue soared 44.72% in 2021 before it tumbled 49.94% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $2.0 million in 2021, then tumbled by 31.35% to $1.4 million in 2022, then dropped by 12.28% to $1.2 million in 2023, then fell by 9.97% to $1.1 million in 2024, then tumbled by 45.29% to $598000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $598000.0 in Q4 2025, $430000.0 in Q3 2025, and $806000.0 in Q2 2025.